Biodesix Inc (BDSX) stock

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30

$9.79−0.33 (-3.26%)

Close on Nov 12, 2026Market cap $103.30MP/E –Yield –

Biodesix EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Biodesix's EPS for the twelve months ending Sep 30, 2026 was -$2.76. For fiscal 2025 it was -$4.67. The highest annual figure on record is -$0.64 in fiscal 2023.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$4.67	–
FY2024	Dec 31, 2024	-$6.64	–
FY2023	Dec 31, 2023	-$0.64	–
FY2022	Dec 31, 2022	-$1.55	–
FY2021	Dec 31, 2021	-$1.58	–
FY2020	Dec 31, 2020	-$6.48	–
FY2019	Dec 31, 2019	-$126.97	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.75	–
Q2 FY2026	Jun 30, 2026	-$0.71	–
Q1 FY2026	Mar 31, 2026	-$0.81	–
Q4 FY2025	Dec 31, 2025	-$0.49	–
Q3 FY2025	Sep 30, 2025	-$1.16	–
Q2 FY2025	Jun 30, 2025	-$1.56	–
Q1 FY2025	Mar 31, 2025	-$1.52	–
Q3 FY2024	Sep 30, 2024	-$1.40	–
Q2 FY2024	Jun 30, 2024	-$0.08	–
Q1 FY2024	Mar 31, 2024	-$0.14	–
Q4 FY2023	Dec 31, 2023	-$0.10	–
Q3 FY2023	Sep 30, 2023	-$0.14	–
Q2 FY2023	Jun 30, 2023	-$0.17	–
Q1 FY2023	Mar 31, 2023	-$0.24	–
Q4 FY2022	Dec 31, 2022	-$0.35	–
Q3 FY2022	Sep 30, 2022	-$0.34	–
Q2 FY2022	Jun 30, 2022	-$0.40	–
Q1 FY2022	Mar 31, 2022	-$0.50	–
Q4 FY2021	Dec 31, 2021	-$0.49	–
Q3 FY2021	Sep 30, 2021	-$0.41	–
Q2 FY2021	Jun 30, 2021	-$0.41	–
Q1 FY2021	Mar 31, 2021	-$0.41	–
Q3 FY2020	Sep 30, 2020	-$31.93	–
Q2 FY2020	Jun 30, 2020	-$30.06	–
Q1 FY2020	Mar 31, 2020	-$37.18	–
Q4 FY2019	Dec 31, 2019	-$24.26	–
Q3 FY2019	Sep 30, 2019	-$39.35	–